Clinical Trials Directory

Trials / Conditions / Larynx Cancer

Larynx Cancer

44 registered clinical trials studyying Larynx Cancer8 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingCApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE)
NCT07254962
Sir Mortimer B. Davis - Jewish General HospitalPhase 2
RecruitingA Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Canc
NCT07063212
Memorial Sloan Kettering Cancer CenterPhase 2
RecruitingLymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma
NCT06706401
Centre Leon BerardPhase 3
CompletedEvaluations of Alcohol Warning Labels
NCT06129487
University of ConnecticutN/A
WithdrawnA Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor
NCT04892875
Jennifer ChoePhase 1
RecruitingMulti-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
NCT05793151
Medical University of South CarolinaN/A
RecruitingNeoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal
NCT06039631
Fudan UniversityPhase 2
WithdrawnGI Organ Tracking Via Balloon Applicators
NCT05471401
Washington University School of MedicineN/A
Active Not RecruitingThe ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors
NCT05798780
H. Lee Moffitt Cancer Center and Research InstituteN/A
CompletedPhonatory Movement of the Pharyngoesophageal Mucosa in Laryngectomy Patients
NCT05561920
Osijek University Hospital
UnknownImmunological Function After Radiation With Either Proton or Photon Therapy
NCT06016699
University Medical Center Groningen
CompletedEvaluation of the French Translation of Swallowing (SOAL-VF) Patient Reported Outcomes (PRO) After Total Phary
NCT05497947
Centre Hospitalier de Valence
RecruitingSpecial Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy
NCT05337631
University Hospital Freiburg
CompletedThe Registry of Oncology Outcomes Associated With Testing and Treatment
NCT04028479
Taproot Health
UnknownQuality of Life and Voice Perception in Patients Laryngoctomized Phonatory Wearers
NCT06086119
Regina Elena Cancer Institute
RecruitingCONFIRM: Magnetic Resonance Guided Radiation Therapy
NCT04368702
Brigham and Women's HospitalN/A
CompletedBilateral Elective Neck Dissection in Salvage Total Laryngectomy
NCT05746780
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RecruitingVoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer
NCT04057209
Olgun ElicinN/A
Active Not RecruitingVocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer
NCT03759431
Centre hospitalier de l'Université de Montréal (CHUM)Phase 2
CompletedComparison Between a Standard Tube and the Ultra-thin Tritube for Intubation of the Trachea and for Maintainin
NCT03653039
Michael Seltz KristensenN/A
CompletedStudy of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Ge
NCT03602079
Klus Pharma Inc.Phase 1 / Phase 2
CompletedAn Investigation of Biomarker Candidate Molecules in Laryngeal Carcinoma
NCT05217147
Hacettepe University
TerminatedUse of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/Pharyngectomy
NCT03479463
MiMedx Group, Inc.
Active Not RecruitingCarboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Car
NCT03174275
UNC Lineberger Comprehensive Cancer CenterPhase 2
CompletedWEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer
NCT03028766
University of BirminghamPhase 1
CompletedPembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinom
NCT03082534
University of California, San DiegoPhase 2
CompletedAdaptive Radiotherapy for Head and Neck Cancer
NCT03096808
Memorial Sloan Kettering Cancer CenterPhase 2
UnknownCell-free Tumor DNA in Head and Neck Cancer Patients
NCT03942380
Christian von BuchwaldN/A
CompletedPembrolizumab in Combination With CRT for LA-SCCHN
NCT02586207
Sanford HealthPhase 1
CompletedEvaluation of a Web-based Decision Aid Tool for Larynx Cancer (T3/T4) Patients.
NCT03292341
Maastricht Radiation OncologyN/A
CompletedBreath Testing in Early and Late Larynx Cancer
NCT01700647
Royal Brisbane and Women's Hospital
UnknownInduction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial
NCT01073683
Rabin Medical CenterPhase 2
CompletedTransoral Laser Surgery and Radiotheraphy for Early Stage Laryngeal Squamous Cell Cancer
NCT04778306
Saglik Bilimleri UniversitesiN/A
CompletedClinical Feasibility of New Tracheoesophageal Puncture Set
NCT01045057
Atos Medical ABN/A
TerminatedMRI Laryngeal Imaging With a Surface Coil
NCT00965003
Stanford UniversityEARLY_Phase 1
CompletedNicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer
NCT01084733
Mahesh Kudrimoti
CompletedRandomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in
NCT00359645
Gustave Roussy, Cancer Campus, Grand ParisPhase 3
CompletedFunctional Voice and Speech Outcomes Following Surgical Voice Restorations: A Comparison of Pharyngeal Constru
NCT00600223
Memorial Sloan Kettering Cancer Center
CompletedRadiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preserv
NCT00169247
Groupe Oncologie Radiotherapie Tete et CouPhase 2
CompletedInduction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Car
NCT00169182
Groupe Oncologie Radiotherapie Tete et CouPhase 3
CompletedPatient Selection for Hypoxia Modifying Treatments in Larynx Carcinomas
NCT00160095
Radboud University Medical Center
CompletedAccelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC
NCT00158652
Groupe Oncologie Radiotherapie Tete et CouPhase 3
CompletedVery Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC
NCT00162708
Gustave Roussy, Cancer Campus, Grand ParisPhase 2 / Phase 3
TerminatedMotexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cance
NCT00080028
Pharmacyclics LLC.Phase 1